Ketogenic therapy for schizophrenia: evidence, mechanisms, and clinical perspectives

Ketogenic therapy for schizophrenia: evidence, mechanisms, and clinical perspectives

IntroductionSchizophrenia is a chronic psychiatric disorder marked by significant cognitive and functional impairments. Current antipsychotic treatments offer limited benefit for negative symptoms and cognitive dysfunction while often exacerbating metabolic comorbidities. Emerging evidence implicate...

Full description

Saved in:
Bibliographic Details
Main Authors: Cristiano Chaves, Jennifer Fabe, Fabiano A. Gomes, Heather McNeely, Massimo Tusconi, Mauro Giovanni Carta, Serdar M. Dursun, Jaime E. C. Hallak, Elisa Brietzke
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Pharmacology
Subjects:
schizophrenia
ketogenic metabolic therapy (KMT)
mitochondrial dysfunction
glucose metabolism
cognitive impairment
treatment resistance
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1603722/full
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2025.1603722/full

Similar Items